Cargando…
L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report
Valproic acid is a broad-spectrum anticonvulsant that has also gained attention in the psychiatric setting. With respect to safety, valproic acid may induce a seemingly rare condition, hyperammonemia, which can induce a wide variety of symptoms ranging from irritability to coma. The proposed mechani...
Autores principales: | Maldonado, Cecilia, Guevara, Natalia, Silveira, Alicia, Fagiolino, Pietro, Vázquez, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536406/ https://www.ncbi.nlm.nih.gov/pubmed/28425821 http://dx.doi.org/10.1177/0300060517703278 |
Ejemplares similares
-
Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014) -
Lamotrigine-Valproic Acid Interaction Leading to Stevens–Johnson Syndrome
por: Vázquez, Marta, et al.
Publicado: (2018) -
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia
por: Maldonado, Cecilia, et al.
Publicado: (2016) -
Valproic Acid-Induced Hyperammonemia in the Elderly: A Review of the Literature
por: Mittal, Vikrant, et al.
Publicado: (2009) -
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
por: Umpiérrez, Martín, et al.
Publicado: (2021)